HAHN MARK W (Chief Financial Officer) sold 3.2% of their position (400K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $4.56M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/13/2025ACC: 0001104659-25-059403
Officer· Chief Financial Officer
Since Jan 2021
-400K
Net shares
Net seller
$4.56M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
400K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−400K
Price / share
$11.40
Trade value
$4.56M
% of position
3.2%
6/11/2025
12.68M→12.28M
Total
Net shares
−400K
Net value
-$4.56M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/11/2025 | S · Sale | −400K | $11.40 | $4.56M | 3.2% | 12.68M | 12.28M |
| Total | −400K | -$4.56M | ||||||
Derivative Transactions0
No derivative transactions reported